Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Biography—David Menter

Biography—David Menter CancerMetastasisRev(2017)36:191 DOI 10.1007/s10555-017-9676-y Springer Science+Business Media, LLC 2017 Waun Ki Hong, M.D., to develop the Lung Cancer Biomarkers Core Program in the Department of Thoracic/Head and Neck Medical Oncology. Several years later, the trio would work to- gether once more to provide the infrastructure for the Biomarker-integrated Approaches of Targeted Therapy for Lung Cancer Elimination (BATTLE) trials. He was first to study the role of neurotrophins in brain cancer metastasis and to im- plement the use of CreERT conditionally targeted mice to exam- ine the role of selenium and selenoproteins in prostate cancer. More recently, Dr. Menter worked with Drs. Raymond DuBois, M.D., Ph.D., and Ernest Hawk, M.D., M.P.H, where he gained extensive experience with NSAIDs COXIBs and aspirin and colorectal cancer biology. He also developed experience with development of nanoparticle delivery vehicles for the treatment of GI cancers and the development of next-generation animal David Menter, Ph.D., is an assistant professor of Gastrointestinal models of GI cancers. He helped found ACF-Pharmaceuticals Medical Oncology at the MD Anderson Cancer Center. He LLP and serves on its executive board as a member and as chief trained with Kenneth Honn, Ph.D., and Lawrence Marnett, scientific officer. He is involved in establishing http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Cancer and Metastasis Reviews Springer Journals

Biography—David Menter

Cancer and Metastasis Reviews , Volume 36 (2) – Aug 15, 2017
Download PDF
1 page

Biography—David Menter

Abstract

CancerMetastasisRev(2017)36:191 DOI 10.1007/s10555-017-9676-y Springer Science+Business Media, LLC 2017 Waun Ki Hong, M.D., to develop the Lung Cancer Biomarkers Core Program in the Department of Thoracic/Head and Neck Medical Oncology. Several years later, the trio would work to- gether once more to provide the infrastructure for the Biomarker-integrated Approaches of Targeted Therapy for Lung Cancer Elimination (BATTLE) trials. He was first to study the role of neurotrophins in brain cancer...
Loading next page...
 
/lp/springer_journal/biography-david-menter-xXQewubo07

References (0)

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
Springer Journals
Copyright
Copyright © 2017 by Springer Science+Business Media, LLC
Subject
Biomedicine; Cancer Research; Oncology; Biomedicine, general
ISSN
0167-7659
eISSN
1573-7233
DOI
10.1007/s10555-017-9676-y
pmid
28812289
Publisher site
See Article on Publisher Site

Abstract

CancerMetastasisRev(2017)36:191 DOI 10.1007/s10555-017-9676-y Springer Science+Business Media, LLC 2017 Waun Ki Hong, M.D., to develop the Lung Cancer Biomarkers Core Program in the Department of Thoracic/Head and Neck Medical Oncology. Several years later, the trio would work to- gether once more to provide the infrastructure for the Biomarker-integrated Approaches of Targeted Therapy for Lung Cancer Elimination (BATTLE) trials. He was first to study the role of neurotrophins in brain cancer metastasis and to im- plement the use of CreERT conditionally targeted mice to exam- ine the role of selenium and selenoproteins in prostate cancer. More recently, Dr. Menter worked with Drs. Raymond DuBois, M.D., Ph.D., and Ernest Hawk, M.D., M.P.H, where he gained extensive experience with NSAIDs COXIBs and aspirin and colorectal cancer biology. He also developed experience with development of nanoparticle delivery vehicles for the treatment of GI cancers and the development of next-generation animal David Menter, Ph.D., is an assistant professor of Gastrointestinal models of GI cancers. He helped found ACF-Pharmaceuticals Medical Oncology at the MD Anderson Cancer Center. He LLP and serves on its executive board as a member and as chief trained with Kenneth Honn, Ph.D., and Lawrence Marnett, scientific officer. He is involved in establishing

Journal

Cancer and Metastasis Reviews – Springer Journals

Published: Aug 15, 2017

There are no references for this article.